Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer

作者
S X Liu,Zhi Xie,Lixu Yan,Guang‐Ling Jie,Jia‐Yi Deng,Qingling Zhang,Zhan Huang,Jin Wang,Zhou Zhang,Yang Shao,Hao Meng,Yan Zhang,Xu‐Chao Zhang,Hua-Jun Chen,Wen‐Zhao Zhong,Qing Zhou,Yi-Long Wu
出处
期刊:Lung cancer [Dove Medical Press]
卷期号:Volume 17: 1-12
标识
DOI:10.2147/lctt.s596080
摘要

Introduction: MET amplification is a critical oncogenic driver and a major mechanism of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer (NSCLC). Currently, next-generation sequencing (NGS)-based assays are increasingly used in clinical practice. However, they lack a unified standard for defining MET amplification across multiple NGS platforms with a potential actionable threshold. Methods: This was a multiple-site joint study to optimize the cut-off value for MET amplification using tumor tissue and NGS analysis. In the training cohort, five NGS panels were used to detect MET gene copy number (GCN), and fluorescence in situ hybridization (FISH) was used as a reference. Receiver operating characteristic (ROC) curve analysis was used to identify the optimal cutoff with 100% specificity and 66.7% sensitivity. The results were validated in an independent cohort to explore the correlation between MET amplification and efficacy of MET inhibitors in patients with NSCLC. Results: In the training cohort (n=21), the optimal MET GCN cut-off was determined to be 6.55, yielding an area under the curve of 0.9, corresponding to an accuracy of 85.7%. MET polysomy, identified using FISH (n=2), was also detected using NGS. All five NGS panels demonstrated good concordance with FISH, with accuracies ranging from 75.0% to 85.7%. In the validation cohort (n=29), NGS analysis demonstrated a good performance, with an accuracy rate of 79.3%. Patients with MET GCN ≥ 6.55 had a significantly longer median progression free survival than those with MET GCN < 6.55 (hazard ratio = 0.42; p = 0.03). Conclusion: In this study, an exploratory cut-off of 6.55 for MET GCN by NGS was associated with MET amplification and longer progression-free survival in patients receiving targeted therapy. However, given the retrospective design and limited sample size, these findings should be regarded as exploratory and require validation in larger, prospective cohorts before broader clinical application. Keywords: MET amplification, next-generation of sequencing, gene copy number, non-small-cell lung cancer, targeted therapy
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Coco发布了新的文献求助10
刚刚
fortuna发布了新的文献求助10
刚刚
刚刚
joy完成签到,获得积分10
刚刚
小马甲的应助被跳跃妙竹采纳,获得10
1秒前
1秒前
彭于晏的应助被jackmilton采纳,获得10
1秒前
1秒前
LS完成签到,获得积分10
1秒前
1秒前
1秒前
ssh发布了新的文献求助10
1秒前
开朗书双发布了新的文献求助10
1秒前
小行星完成签到,获得积分10
2秒前
Mok完成签到,获得积分10
2秒前
刘承昭发布了新的文献求助10
2秒前
Rittie21发布了新的文献求助10
3秒前
笑点低的代容完成签到,获得积分10
3秒前
在水一方的应助被Colin采纳,获得10
3秒前
科研废物完成签到 ,获得积分10
4秒前
1522完成签到,获得积分10
4秒前
大个的应助被hxc采纳,获得10
4秒前
4秒前
青橙发布了新的文献求助20
5秒前
5秒前
5秒前
5秒前
5秒前
六道完成签到,获得积分10
5秒前
秋风的应助被DYY采纳,获得20
6秒前
田様的应助被刘承昭采纳,获得10
6秒前
StevenZhao完成签到,获得积分0
6秒前
tomatoGG发布了新的文献求助10
6秒前
Firsterchao发布了新的文献求助10
6秒前
ssh完成签到,获得积分10
6秒前
yexing完成签到,获得积分10
6秒前
去吃火锅发布了新的文献求助10
6秒前
安静诗霜发布了新的文献求助10
7秒前
须臾发布了新的文献求助10
7秒前
Mauve完成签到,获得积分20
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160268
求助须知:如何正确求助?哪些是违规求助? 9555328
关于积分的说明 21727231
捐赠科研通 7750062
什么是DOI,文献DOI怎么找? 3427353
关于科研通互助平台的介绍 2552391
邀请新用户注册赠送积分活动 2471707